Den gennemsnitlige overlevelse var 19, 3 måneder for patienter randomiseret til Nexavar sammenlignet med 15, 9 måneder for placebopatienterne (HR = 0, 77; 95% CI:
The median survival was 19.3 months for patients randomised to Nexavar compared to 15.9 months for placebo patients (HR = 0.77; 95% CI: